{"title": "Nefropat\u00eda isqu\u00e9mica: patog\u00e9nesis y tratamiento | Nefrolog\u00eda", "author": "Adamczak; Marcin; Wiecek; Andrzej", "url": "http://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-resumen-X0211699512001653", "hostname": "revistanefrologia.com", "description": "En esta revisi\u00f3n nos gustar\u00eda realizar un resumen del conocimiento actual sobre la", "sitename": "Nefrolog\u00eda", "date": "2012-07-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "En esta revisi\u00f3n nos gustar\u00eda realizar un resumen del conocimiento actual sobre la patog\u00e9nesis y el tratamiento de la nefropat\u00eda isqu\u00e9mica. Los datos epidemiol\u00f3gicos sugieren que la prevalencia de la nefropat\u00eda isqu\u00e9mica aumenta, especialmente en los individuos de mayor edad. La patog\u00e9nesis de esta enfermedad es m\u00e1s compleja que el mero estrechamiento de la arteria renal a causa de la ateroesclerosis. El sistema renina angiotensina, los factores de crecimiento, las diferentes citoquinas y las quimiocinas pueden estar implicados en la patog\u00e9nesis de la nefropat\u00eda isqu\u00e9mica. Espec\u00edficamente, los criterios diagn\u00f3sticos de utilidad cl\u00ednica de la nefropat\u00eda isqu\u00e9mica a\u00fan est\u00e1n por determinar. La gesti\u00f3n m\u00e9dica acordada de forma conjunta sigue siendo por el momento la principal opci\u00f3n terap\u00e9utica para la mayor\u00eda de los pacientes con esta patolog\u00eda y hoy en d\u00eda, la revascularizaci\u00f3n est\u00e1 indicada \u00fanicamente en pacientes seleccionados.\nIn this review paper we would like to summarized the current knowledge concerning the pathogenesis and treatment of ischemic nephropathy. Epidemiological data suggest that the prevalence of ischemic nephropathy increases, especially among older individuals. The pathogenesis of this disease is more complex than just narrowing of the renal artery due to atherosclerosis. Renin-angiotension system, growth factors, different cytokines and chemokines may participate in the pathogenesis of ischemic nephropathy. Precise, clinically useful diagnostic criteria of the ischemic nephropathy have not been established, yet. Concerted medical management remains now the main therapeutic option for majority of patients with this disease and only in the selected patients revascularisation is nowadays indicated.\n[[1]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/10625716) [[2]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9800739) [[3]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/8060577) [[4]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/15954920) [[5]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9527401) [[6]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11576364) [[7]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/10658941) [[8]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/3364444) [[9]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/2523265) [[10]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/7564074) [[11]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/12748348) [[12]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/7942820) [[13]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11382687) [[14]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/7305653) [[15]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/6464247) [[16]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9507221) [[18]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9016887) [[19]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/20501460) [[20]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/10487768) [[21]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/2255186) [[22]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9648058) [[23]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/1635158) [[24]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/10405201) [[25]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9050035) [[26]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11592947) [[27]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/18725503) [[28]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11856789) [[29]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11274271) [[30]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/10809803) [[31]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11752032) [[32]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/18971350) [[33]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/16411163) [[34]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/21885971) [[35]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/20194303) [[36]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/1582137) [[37]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/1314993) [[38]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/16291837) [[39]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/17084261) [[40]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/19917330) [[41]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11230332) [[42]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/12075056) [[43]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/12451006) [[44]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11792641) [[45]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/19153272) [[46]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/10627871) [[47]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/15308558) [[48]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/18622245) [[49]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/19934087) [[50]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/20506499) [[51]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/20501462) [[52]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/9016887) [[53]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/11172177) [[54]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/16301720) [[55]] [[Pubmed]](http://www.ncbi.nlm.nih.gov/pubmed/22773240)", "language": null, "image": "https://multimedia.elsevier.es/PublicationsMultimediaV1/revista/cover/02116995?idApp=UINPBA000064", "pagetype": "article", "links": ["/", "es-busqueda-avanzada", "/es-compartir-twitter?item=X0211699512001653", "/es-compartir-facebook?item=X0211699512001653", "/es-compartir-linkedin?item=X0211699512001653", "whatsapp://send?text=http://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-resumen-X0211699512001653", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Nefropat%C3%ADa%20isqu%C3%A9mica%3A%20patog%C3%A9nesis%20y%20tratamiento&body=https://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "/es-guia-autores", "/es-compartir-twitter?item=X0211699512001653", "/es-compartir-facebook?item=X0211699512001653", "/es-compartir-linkedin?item=X0211699512001653", "whatsapp://send?text=http://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-resumen-X0211699512001653", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Nefropat%C3%ADa%20isqu%C3%A9mica%3A%20patog%C3%A9nesis%20y%20tratamiento&body=https://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "es-busqueda-avanzada", "/es-vol-32-num-4-sumario-X0211699512X00080", "/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "/es", "/es-ahead-of-print", "/es-vol-43-num-5-sumario-S0211699523X00058", "/es-numeros-anteriores", "/es-suplementos", "https://www.revistanefrologia.com/es-monografias-nefrologia", "https://www.revistanefrologia.com/es-suplementos-extraordinarios", "https://www.revistanefrologia.com/es-nefroplus", "https://www.revistanefrologia.com/es-casos-cerrados", "https://www.revistanefrologia.com/es-libro-historia-nefrologia", "https://nefrologiaaldia.org/", "https://www.revistanefrologia.com/es-otras-publicaciones", "/es-alerta-email", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-acerca-revista", "/es-comite-editorial", "https://www.senefro.org/modules.php?name=webstructure&idwebstructure=6", "mailto:revistanefrologia@elsevier.com", "/es-contratar", "/es-mas-leidos", "/es-metricas", "https://www.revistanefrologia.com/es-open-access", "https://multimedia.elsevier.es/PublicationsMultimediaV1/revista/cover/02116995?idApp=UINPBA000064", "https://static.elsevier.es/miscelanea/SSCC-FACME_nefro.pdf", "https://static.elsevier.es/miscelanea/SSCC-FACME_nefro.pdf", "https://twitter.com/SENefrologia", "/es-rss-ultimo", "/es-metricas#factorimpacto", "/es-metricas#citescore", "/es-metricas#sjr", "/es-metricas#snip", "/es-metricas", "/es-importancia-del-donante-anoso-como-articulo-X0211699512001661", "/es-la-situacion-laboral-del-paciente-articulo-X0211699512001645", "/es-vol-32-num-4-sumario-X0211699512X00080", "/en-ischemic-nephropathy-39-pathogenesis-treatment-articulo-X2013251412001650", "/es-exportar-rif-X0211699512001653", "/es-compartir-twitter?item=X0211699512001653", "/es-compartir-facebook?item=X0211699512001653", "/es-compartir-linkedin?item=X0211699512001653", "whatsapp://send?text=http://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Nefropat%C3%ADa%20isqu%C3%A9mica%3A%20patog%C3%A9nesis%20y%20tratamiento&body=https://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "javascript:imprimirItem()", "/es-pdf-X0211699512001653", "/es-epub-X0211699512001653", "/es-estadisticas-X0211699512001653", "/es-vol-32-num-4-sumario-X0211699512X00080", "/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "/index.php?p=revista&tipo=pdf-simple&pii=X0211699512001653", "#affa", "#affa", null, "/es-estadisticas-X0211699512001653", "/es-estadisticas-X0211699512001653", "/es-pdf-X0211699512001653", null, "http://www.ncbi.nlm.nih.gov/pubmed/10625716", null, "http://www.ncbi.nlm.nih.gov/pubmed/9800739", null, "http://www.ncbi.nlm.nih.gov/pubmed/8060577", null, "http://www.ncbi.nlm.nih.gov/pubmed/15954920", null, "http://www.ncbi.nlm.nih.gov/pubmed/9527401", null, "http://www.ncbi.nlm.nih.gov/pubmed/11576364", null, "http://www.ncbi.nlm.nih.gov/pubmed/10658941", null, "http://www.ncbi.nlm.nih.gov/pubmed/3364444", null, "http://www.ncbi.nlm.nih.gov/pubmed/2523265", null, "http://www.ncbi.nlm.nih.gov/pubmed/7564074", null, "http://www.ncbi.nlm.nih.gov/pubmed/12748348", null, "http://www.ncbi.nlm.nih.gov/pubmed/7942820", null, "http://www.ncbi.nlm.nih.gov/pubmed/11382687", null, "http://www.ncbi.nlm.nih.gov/pubmed/7305653", null, "http://www.ncbi.nlm.nih.gov/pubmed/6464247", null, "http://www.ncbi.nlm.nih.gov/pubmed/9507221", null, "http://www.ncbi.nlm.nih.gov/pubmed/8720083", null, "http://www.ncbi.nlm.nih.gov/pubmed/9016887", null, "http://www.ncbi.nlm.nih.gov/pubmed/20501460", null, "http://www.ncbi.nlm.nih.gov/pubmed/10487768", null, "http://www.ncbi.nlm.nih.gov/pubmed/2255186", null, "http://www.ncbi.nlm.nih.gov/pubmed/9648058", null, "http://www.ncbi.nlm.nih.gov/pubmed/1635158", null, "http://www.ncbi.nlm.nih.gov/pubmed/10405201", null, "http://www.ncbi.nlm.nih.gov/pubmed/9050035", null, "http://www.ncbi.nlm.nih.gov/pubmed/11592947", null, "http://www.ncbi.nlm.nih.gov/pubmed/18725503", null, "http://www.ncbi.nlm.nih.gov/pubmed/11856789", null, "http://www.ncbi.nlm.nih.gov/pubmed/11274271", null, "http://www.ncbi.nlm.nih.gov/pubmed/10809803", null, "http://www.ncbi.nlm.nih.gov/pubmed/11752032", null, "http://www.ncbi.nlm.nih.gov/pubmed/18971350", null, "http://www.ncbi.nlm.nih.gov/pubmed/16411163", null, "http://www.ncbi.nlm.nih.gov/pubmed/21885971", null, "http://www.ncbi.nlm.nih.gov/pubmed/20194303", null, "http://www.ncbi.nlm.nih.gov/pubmed/1582137", null, "http://www.ncbi.nlm.nih.gov/pubmed/1314993", null, "http://www.ncbi.nlm.nih.gov/pubmed/16291837", null, "http://www.ncbi.nlm.nih.gov/pubmed/17084261", null, "http://www.ncbi.nlm.nih.gov/pubmed/19917330", null, "http://www.ncbi.nlm.nih.gov/pubmed/11230332", null, "http://www.ncbi.nlm.nih.gov/pubmed/12075056", null, "http://www.ncbi.nlm.nih.gov/pubmed/12451006", null, "http://www.ncbi.nlm.nih.gov/pubmed/11792641", null, "http://www.ncbi.nlm.nih.gov/pubmed/19153272", null, "http://www.ncbi.nlm.nih.gov/pubmed/10627871", null, "http://www.ncbi.nlm.nih.gov/pubmed/15308558", null, "http://www.ncbi.nlm.nih.gov/pubmed/18622245", null, "http://www.ncbi.nlm.nih.gov/pubmed/19934087", null, "http://www.ncbi.nlm.nih.gov/pubmed/20506499", null, "http://www.ncbi.nlm.nih.gov/pubmed/20501462", null, "http://www.ncbi.nlm.nih.gov/pubmed/9016887", null, "http://www.ncbi.nlm.nih.gov/pubmed/11172177", null, "http://www.ncbi.nlm.nih.gov/pubmed/16301720", null, "http://www.ncbi.nlm.nih.gov/pubmed/22773240", null, "http://www.ncbi.nlm.nih.gov/pubmed/18287564", "/es-decision-making-should-we-articulo-S0211699522000856?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-manejo-inmunosupresion-pacientes-trasplantados-rinon-avance-S0211699522000765?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-enfermedad-renal-el-covid-19-persistente-articulo-S0211699522000819?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-hipocloremia-asociada-una-mayor-incidencia-avance-S0211699522000170?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-covid", "javascript:imprimirItem()", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Nefropat%C3%ADa%20isqu%C3%A9mica%3A%20patog%C3%A9nesis%20y%20tratamiento&body=https://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "/es-exportar-rif-X0211699512001653", "http://www.mendeley.com/import/?url=http://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-resumen-X0211699512001653", "/es-estadisticas-X0211699512001653", "https://plu.mx/plum/a/?doi=10.3265/Nefrologia.pre2012.Apr.11472", "/es-importancia-prescripcion-ejercicio-fisico-pacientes-articulo-S0211699522000418", "/es-does-uric-acid-lowering-treatment-slow-articulo-S0211699522000790", "/es-validation-kidney-failure-risk-equation-articulo-S0211699522000716", "http://www.senefro.org", "http://creativecommons.org/licenses/by-nc-nd/4.0/", "http://creativecommons.org/licenses/by-nc-nd/4.0/", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "http://www.nefrologiaaldia.org/es", "https://www.friat.es/", "/es-ahead-of-print", "/", "/es-mas-leidos", "/es-numeros-anteriores", "/es-suplementos", "es-monografias-nefrologia", "/es-suplementos-extraordinarios", "/es-nefroplus", "/es-casos-cerrados", "/es-otras-publicaciones", "/es-libro-historia-nefrologia", "http://www.nefrologialdia.org", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-comite-editorial", "/es-permisos-reproduccion", "https://www.elsevier.com/legal/elsevier-website-terms-and-conditions", "https://www.elsevier.com/legal/privacy-policy-es-es", "/es-contratar", "/es-alerta-email", "/es-rss-ultimo", "/es-contratar", "/es-contacto", "/es-comite-editorial", null, "/es", "/en", "/es", "/es-ahead-of-print", "/es-vol-43-num-5-sumario-S0211699523X00058", "/es-numeros-anteriores", "/es-suplementos", "https://www.revistanefrologia.com/es-monografias-nefrologia", "https://www.revistanefrologia.com/es-suplementos-extraordinarios", "https://www.revistanefrologia.com/es-nefroplus", "https://www.revistanefrologia.com/es-casos-cerrados", "https://www.revistanefrologia.com/es-libro-historia-nefrologia", "https://nefrologiaaldia.org/", "https://www.revistanefrologia.com/es-otras-publicaciones", "/es-alerta-email", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-acerca-revista", "/es-comite-editorial", "https://www.senefro.org/modules.php?name=webstructure&idwebstructure=6", "mailto:revistanefrologia@elsevier.com", "/es-contratar", "/es-mas-leidos", "/es-metricas", "https://www.revistanefrologia.com/es-open-access", "/en-ischemic-nephropathy-39-pathogenesis-treatment-articulo-X2013251412001650", "/index.php?p=revista&tipo=pdf-simple&pii=X0211699512001653&r=100", "#bibliografia", "javascript:imprimirItem()", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Nefropat%C3%ADa%20isqu%C3%A9mica%3A%20patog%C3%A9nesis%20y%20tratamiento&body=https://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-X0211699512001653", "/es-exportar-rif-X0211699512001653", "http://www.mendeley.com/import/?url=http://www.revistanefrologia.com/es-nefropatia-isquemica-patogenesis-tratamiento-articulo-resumen-X0211699512001653", "/es-estadisticas-X0211699512001653", "https://plu.mx/plum/a/?doi=10.3265/Nefrologia.pre2012.Apr.11472"]}